Dec 8, 2011 | Freshnews
Radient Pharmaceuticals Submits an Abstract to the American Society of Colon and Rectal Surgeons
Radient Pharmaceuticals Corporation , developer and marketer of the Onko-Sure In Vitro Diagnostic cancer test, announced today that it has submitted one abstract for the American Society of Colon and Rectal Surgeons' Annual Meeting to be held in June 2012.
Also on Topix